Highlights and Quick Summary
- Long-term assets (Other) for the quarter ending September 30, 2022 was $14.6 Million (a -2.3% decrease compared to previous quarter)
- Year-over-year quarterly Long-term assets (Other) increased by 1.06%
- Annual Long-term assets (Other) for 2021 was $14.5 Million (a -19.54% decrease from previous year)
- Annual Long-term assets (Other) for 2020 was $18 Million (a -1.77% decrease from previous year)
- Annual Long-term assets (Other) for 2019 was $18.3 Million (a 921.08% increase from previous year)
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long-term assets (Other) of Beam Therapeutics Inc.
Most recent Long-term assets (Other)of BEAM including historical data for past 10 years.Interactive Chart of Long-term assets (Other) of Beam Therapeutics Inc.
Beam Therapeutics Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $14.62 | $14.97 | $14.09 | – |
| 2021 | $14.47 | $15.89 | $16.0 | $19.87 | $14.47 |
| 2020 | $17.98 | $18.39 | $16.55 | $16.08 | $17.98 |
| 2019 | – | – | – | $18.31 | $18.31 |
| 2018 | $1.79 | – | – | – | $1.79 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology